A Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SRK-001 in Healthy Participants

NCT05156034 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Due to occurrence of eye related adverse events.

Conditions

Healthy Participants

Interventions

DRUG: SRK-001
DRUG: Placebo

Sponsor

Sarkana Pharma Inc